First Wilshire Securities Management Inc Trinity Biotech PLC Transaction History

First Wilshire Securities Management Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$0.62 - $1.47 $328,381 - $778,581	-529,647 Closed	0 $0
Q4 2019 Feb 18, 2020	SELL	$0.69 - $1.2 $168,002 - $292,178	-243,482 Reduced 31.49%	529,647 $547,000
Q3 2019 Nov 14, 2019	SELL	$1.21 - $2.59 $25,506 - $54,597	-21,080 Reduced 2.65%	773,129 $935,000
Q2 2019 Aug 14, 2019	SELL	$1.57 - $3.02 $293,613 - $564,785	-187,015 Reduced 19.06%	794,209 $1.31 Million
Q1 2019 May 16, 2019	SELL	$2.31 - $3.22 $19,454 - $27,118	-8,422 Reduced 0.85%	981,224 $2.8 Million
Q4 2018 Feb 15, 2019	SELL	$2.14 - $4.26 $63,804 - $127,011	-29,815 Reduced 2.92%	989,646 $2.27 Million
Q3 2018 Nov 15, 2018	SELL	$3.76 - $5.08 $42,653 - $57,627	-11,344 Reduced 1.1%	1,019,461 $4.08 Million
Q2 2018 Aug 15, 2018	BUY	$4.46 - $5.2 $133,492 - $155,641	29,931 Added 2.99%	1,030,805 $5.15 Million
Q1 2018 May 15, 2018	SELL	$5.08 - $6.06 $130,810 - $156,045	-25,750 Reduced 2.51%	1,000,874 $5.16 Million
Q4 2017 Feb 15, 2018	SELL	$4.5 - $5.77 $185,521 - $237,879	-41,227 Reduced 3.86%	1,026,624 $5.24 Million
Q3 2017 Nov 14, 2017	BUY	$5.16 - $5.67 $5.51 Million - $6.05 Million	1,067,851	1,067,851 $5.99 Million

30.2K

Ticker TRIB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 38,107,600
Market Cap $29M
Description
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious dis...

Get notified when there are updates to the investment portfolio of First Wilshire Securities Management Inc, based on Form 13F filings with the SEC.

Stay updated on First Wilshire Securities Management Inc with notifications on news.